Abstract C108: ANPEP regulates one-carbon metabolism in prostate cancer

Asmaa El-Kenawi,Ryan Putney,Anders Berglund,Kosj Yamoah

DOI: https://doi.org/10.1158/1538-7755.disp24-c108

2024-09-23

Cancer Epidemiology Biomarkers & Prevention

Abstract:In the year 2023, prostate cancer (PCa) contributed to 34,700 cancer-related fatalities within the United States. Notably, African American men (AAM) experience disproportionately higher rates of both PCa incidence and mortality compared to their European American counterparts (EAM). To investigate some of the biological factors which contribute to these disparities, we carried out an unbiased genomic expression analysis of PCa stratified by ancestry using retrospective and prospective clinical cohorts. In these analyses, we identified aminopeptidase N (ANPEP, APN, CD13), as the most differentially expressed gene in both self-identified and ancestry derived AAM compared with EAM. Previous studies demonstrated that the aminopeptidase ANPEP cleaves N termini of numerous hormones, cytokines, and chemokines involved in oncogenic signaling, cancer relapse and Inflammation. Specifically, ANPEP trims peptides with an N-terminal L-alanine and (L-cysteinylglycine)-S-conjugates while releasing alanine and glycine, respectively. While the role of ANPEP in cytokine activation is well studied, the contribution of ANPEP to amino acids homeostasis remains unknown. Herein, we aim to characterize the metabolic function of ANPEP and whether ANPEP regulates therapeutic efficacy. Using computational analyses, we demonstrate that expression of ANPEP predominantly correlates with various amino acid transporters. By employing untargeted metabolomics, we subsequently revealed a significant enrichment of one-carbon metabolism in cells that overexpress ANPEP. The one-carbon metabolism connects a series of metabolic pathways including the methionine cycle which in turn regulates methylation of various cellular substrates. We then performed genome-wide methylation profiling demonstrates that ANPEP overexpression is associated with elevated methylation of DNA. Because elevated methylation of DNA which is a determinant of therapeutic efficacy in prostate cancer, future studies will assess whether ANPEP regulation of methylation capacity impacts therapeutic efficacy and disease progression. To clinically validate our findings, we them carried out a fluxomic approach in ex vivo human tumor slice culture from 20 patients of prostate cancer. These studies demonstrate that PCa from AAM exhibit higher demand for methionine and cystine highlighting dominance of one-carbon metabolism. In conclusion, we discovered a new function of ANPEP in regulating one-carbon metabolism in prostate cancer. Citation Format: Asmaa El-Kenawi, Ryan Putney, Anders Berglund, Kosj Yamoah. ANPEP regulates one-carbon metabolism in prostate cancer [abstract]. In: Proceedings of the 17th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2024 Sep 21-24; Los Angeles, CA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2024;33(9 Suppl) nr C108.

oncology,public, environmental & occupational health